713-814-5022 [email protected]

About China focus @ JPM WEEK


Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.

China [email protected] week is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior and during the forum.

What to expect


Chinese Companies


One-to-one Meetings


Executive Level Attendees


Biotech and Pharma Companies

ATTENDEE DEMOGRAPHICS at China Focus @ Biotech Week Boston

What to expect


Chinese Companies


One-to-one Meetings


Executive Level Attendees


Biotech and Pharma Companies




PD-(L)1联合疗法 CAR-T 疗法 TCR-T 疗法 肿瘤免疫疗法在胃癌中的应用 肿瘤疫苗 溶瘤病毒




罕见病的基因疗法 CRISPR 基因检测




AI在诊断中的应用 AI在新药发现研发中的应用




Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.





Katherine Andersen

Head of Healthcare Corporate Finance and East/Central Life Science, Silicon Valley Bank

Kim Nearing

Managing Director, Cedrus Group

Irene Hong

Founding Partner, CEC Capital Group

James Huang

Managing Partner, KPCB China

Geffrey Gao

Executive VP/Deputy GM, Head of Strategy, BD, Investment and M&A Company, Harbin pharmaceutical group

Bob Ai

Senior Vice President, Solebury Trout (Moderator)

Anjiang (Vincent) Liu

Senior Advisor, Fosun Pharma

Dang Qun

Global BD Head, Qilu Pharma

Weigang Wang

Senior Director, Global Pharma Business Development & Licensing, Chia Tai Tianqing Pharmaceutical

Yuanhua Ding

Head of External R&D, Pifzer

Aaron Chen

Senior Director, Global Business Development & Licensing, Oncology, Bayer Pharmaceuticals

Scott Liu

CEO, Henlius

Daniel Chai

Managing Partner, Turret Capital Management

Nissi Darvish

Senior Managing Director, OrbiMed

Cynthia Cai

Senior Advisor, Northern Light Venture Capital

Linda Ji

Partner, McDermott Will & Emery LLP

Darren Ji

Partner, Lily Asia Ventures

Simon Xu

 3D Medicines Inc

Dennis Purcell

 Founder and Senior Advisor, Aisling Capital (Moderator)


China [email protected] Forum Registration

Early Bird (Before Oct. 15, 2018): $349

Regular (After Oct. 15, 2018): $499



Ticket Type Price End Sales
Early Bird Forum Admission  (register by Oct 15th and save $150) $849.00 * 10/15/18 11:30 PM
Forum Admission - Regular $995.00 * 1/8/19 9:00 AM

*Qualified Investors can request complimentary registration.  A qualified investor is an institutional or venture investor with offshore U.S. dollar funds or have completed an oversea transaction in the past 24 months. Event organizer reserve the right to determine eligibility for this category.

* Members of the press can request for a complimentary registration.

* Public and private companies that have assets for out-licensing are invited to join the 2019 China Focus @ JPM Week presentation and Showcase. Presenting companies will not only receive 15min (10min for PowerPoint presentation and 5min for Q&A) to present during the conference and one dedicated partnering booth, but will also receive pre-conference promotion opportunity, one Chinese-subtitled presentation video, consultation on 1-to-1 partnering and onsite interpretation help.


Reach your ideal audience, demonstrate your thought leadership, increase your brand awareness and more.

We help you reach your goal through flexible sponsorship options.

  Platinum Gold Silver
Sponsorship $10,000 $5,000 $3,000
Exposure Your company logo on banners, programs, event websites and 1-to-1 partnering platform
One Booth
Speaking Opportunity
Consultation on 1-to-1 partnering
Free Tickets to China [email protected] Week 5 3 2
  • 15-30min keynote presentation or participate in a panel discussion with other thought leaders. We welcome KOLs in biotech innovation to share your vision and experience.
  • One ticket to China [email protected] Week
Exhibit booth
  • Display your poster or banner at the Forum at the most visible location in the venue. Ensure that your event presence will make a lasting impression on clients, prospects and partners.
  • Two tickets to China [email protected] Week
Breakfast, lunch and reception sponsorship – please contact us for availability



Livzon Mabpharm

Buchang Pharmaceutical

Sequoia Capital China

Cowin Capital

Fosun Pharma

GenFleet Therapeutics


Hengrui Therapeutics Inc

Chia Tai Tianqing

Qilu Pharmaceutical Ltd

Kelun Pharma

Silicon Valley Bank
Turret Capital Management
Harbin Pharmaceutical Group
Tsingyuan Ventures
Solebury Trout
Salubris Pharma
PhenoVista Biosciences
Onconova Therapeutics
Northern Light Venture Capital
Loncar Investments
LIPAC Oncology
KPCB China
Kaitai Capital
H_Q Asia Pacific
Delos Capital
Carlyle Global Advisors
Berlin Cures
Alps global holding berhad
Aisling Capital
11.2 CapitalUpdated
Berlin Cures
Cedrus Group
Bayer Pharmaceuticals
Delos Living


Registration, Group Delegation and Presenting Companies (China)

Youwen Dai

Email:[email protected]

Registration, Group Delegation and Presenting Companies (U.S.)

Zhongyu Li

Email:[email protected]